Selected research
Industry Research
Aprepitant Preparations Industry Research Report 2026
Market perspective
The global Aprepitant Preparations market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Aprepitant Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Aprepitant Preparations is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Aprepitant Preparations is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Aprepitant Preparations include Glenmark, Sandoz, Torrent Pharmaceuticals, Beijing Sihuan Pharmaceutical, Merck, Qilu pharmaceutical and Chia Tai Tianqing Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Aprepitant Preparations market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Aprepitant Preparations Market by Company
Glenmark
Sandoz
Torrent Pharmaceuticals
Beijing Sihuan Pharmaceutical
Merck
Qilu pharmaceutical
Chia Tai Tianqing Pharmaceutical
Aprepitant Preparations Segment by Type
Oral Form
Injectable Form
Aprepitant Preparations Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Aprepitant Preparations Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aprepitant Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Aprepitant Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aprepitant Preparations.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Aprepitant Preparations manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Aprepitant Preparations by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Aprepitant Preparations in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Form
- Injectable Form
Applications
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Companies covered
- Glenmark
- Sandoz
- Torrent Pharmaceuticals
- Beijing Sihuan Pharmaceutical
- Merck
- Qilu pharmaceutical
- Chia Tai Tianqing Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Aprepitant Preparations Market Size (2021-2032)
- 2.2.2 Global Aprepitant Preparations Sales (2021-2032)
- 2.2.3 Global Aprepitant Preparations Market Average Price (2021-2032)
- 2.3 Aprepitant Preparations by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral Form
- 2.3.3 Injectable Form
- 2.4 Aprepitant Preparations by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacy
- 2.4.3 Online Pharmacy
- 2.4.4 Retail Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Aprepitant Preparations Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Aprepitant Preparations Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Aprepitant Preparations Revenue of Manufacturers (2021-2026)
- 3.4 Global Aprepitant Preparations Average Price by Manufacturers (2021-2026)
- 3.5 Global Aprepitant Preparations Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Aprepitant Preparations, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Aprepitant Preparations, Product Type & Application
- 3.8 Global Manufacturers of Aprepitant Preparations, Established Date
- 3.9 Global Aprepitant Preparations Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Glenmark
- 4.1.1 Glenmark Company Information
- 4.1.2 Glenmark Business Overview
- 4.1.3 Glenmark Aprepitant Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Glenmark Aprepitant Preparations Product Portfolio
- 4.1.5 Glenmark Recent Developments
- 4.2 Sandoz
- 4.2.1 Sandoz Company Information
- 4.2.2 Sandoz Business Overview
- 4.2.3 Sandoz Aprepitant Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sandoz Aprepitant Preparations Product Portfolio
- 4.2.5 Sandoz Recent Developments
- 4.3 Torrent Pharmaceuticals
- 4.3.1 Torrent Pharmaceuticals Company Information
- 4.3.2 Torrent Pharmaceuticals Business Overview
- 4.3.3 Torrent Pharmaceuticals Aprepitant Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Torrent Pharmaceuticals Aprepitant Preparations Product Portfolio
- 4.3.5 Torrent Pharmaceuticals Recent Developments
- 4.4 Beijing Sihuan Pharmaceutical
- 4.4.1 Beijing Sihuan Pharmaceutical Company Information
- 4.4.2 Beijing Sihuan Pharmaceutical Business Overview
- 4.4.3 Beijing Sihuan Pharmaceutical Aprepitant Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Beijing Sihuan Pharmaceutical Aprepitant Preparations Product Portfolio
- 4.4.5 Beijing Sihuan Pharmaceutical Recent Developments
- 4.5 Merck
- 4.5.1 Merck Company Information
- 4.5.2 Merck Business Overview
- 4.5.3 Merck Aprepitant Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Merck Aprepitant Preparations Product Portfolio
- 4.5.5 Merck Recent Developments
- 4.6 Qilu pharmaceutical
- 4.6.1 Qilu pharmaceutical Company Information
- 4.6.2 Qilu pharmaceutical Business Overview
- 4.6.3 Qilu pharmaceutical Aprepitant Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Qilu pharmaceutical Aprepitant Preparations Product Portfolio
- 4.6.5 Qilu pharmaceutical Recent Developments
- 4.7 Chia Tai Tianqing Pharmaceutical
- 4.7.1 Chia Tai Tianqing Pharmaceutical Company Information
- 4.7.2 Chia Tai Tianqing Pharmaceutical Business Overview
- 4.7.3 Chia Tai Tianqing Pharmaceutical Aprepitant Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Chia Tai Tianqing Pharmaceutical Aprepitant Preparations Product Portfolio
- 4.7.5 Chia Tai Tianqing Pharmaceutical Recent Developments
5 Global Aprepitant Preparations Market Scenario by Region
- 5.1 Global Aprepitant Preparations Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Aprepitant Preparations Sales by Region: 2021-2032
- 5.2.1 Global Aprepitant Preparations Sales by Region: 2021-2026
- 5.2.2 Global Aprepitant Preparations Sales by Region: 2027-2032
- 5.3 Global Aprepitant Preparations Revenue by Region: 2021-2032
- 5.3.1 Global Aprepitant Preparations Revenue by Region: 2021-2026
- 5.3.2 Global Aprepitant Preparations Revenue by Region: 2027-2032
- 5.4 North America Aprepitant Preparations Market Facts & Figures by Country
- 5.4.1 North America Aprepitant Preparations Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Aprepitant Preparations Sales by Country (2021-2032)
- 5.4.3 North America Aprepitant Preparations Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Aprepitant Preparations Market Facts & Figures by Country
- 5.5.1 Europe Aprepitant Preparations Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Aprepitant Preparations Sales by Country (2021-2032)
- 5.5.3 Europe Aprepitant Preparations Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Aprepitant Preparations Market Facts & Figures by Country
- 5.6.1 Asia Pacific Aprepitant Preparations Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Aprepitant Preparations Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Aprepitant Preparations Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Aprepitant Preparations Market Facts & Figures by Country
- 5.7.1 South America Aprepitant Preparations Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Aprepitant Preparations Sales by Country (2021-2032)
- 5.7.3 South America Aprepitant Preparations Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Aprepitant Preparations Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Aprepitant Preparations Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Aprepitant Preparations Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Aprepitant Preparations Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Aprepitant Preparations Sales by Type (2021-2032)
- 6.1.1 Global Aprepitant Preparations Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Aprepitant Preparations Sales Market Share by Type (2021-2032)
- 6.2 Global Aprepitant Preparations Revenue by Type (2021-2032)
- 6.2.1 Global Aprepitant Preparations Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Aprepitant Preparations Revenue Market Share by Type (2021-2032)
- 6.3 Global Aprepitant Preparations Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Aprepitant Preparations Sales by Application (2021-2032)
- 7.1.1 Global Aprepitant Preparations Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Aprepitant Preparations Sales Market Share by Application (2021-2032)
- 7.2 Global Aprepitant Preparations Revenue by Application (2021-2032)
- 7.2.1 Global Aprepitant Preparations Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Aprepitant Preparations Revenue Market Share by Application (2021-2032)
- 7.3 Global Aprepitant Preparations Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Aprepitant Preparations Value Chain Analysis
- 8.1.1 Aprepitant Preparations Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Aprepitant Preparations Production Mode & Process
- 8.2 Aprepitant Preparations Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Aprepitant Preparations Distributors
- 8.2.3 Aprepitant Preparations Customers
9 Global Aprepitant Preparations Analyzing Market Dynamics
- 9.1 Aprepitant Preparations Industry Trends
- 9.2 Aprepitant Preparations Industry Drivers
- 9.3 Aprepitant Preparations Industry Opportunities and Challenges
- 9.4 Aprepitant Preparations Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst